(Q64043560)

12 December 2020

Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization

1 reference

12 December 2020

Clinical experience over 48 years with pheochromocytoma

1 reference

12 December 2020

Somatostatin and its receptor family

1 reference

12 December 2020

A malignant primary cardiac pheochromocytoma

1 reference

12 December 2020

Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.

1 reference

12 December 2020

Surgical excision of malignant pheochromocytoma in the left atrium

1 reference

12 December 2020

Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.

1 reference

12 December 2020

Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland

1 reference

12 December 2020

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

1 reference

12 December 2020

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

1 reference

12 December 2020

Increased expression of tenascin in pheochromocytomas correlates with malignancy

1 reference

12 December 2020

Management of malignant phaeochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands

1 reference

12 December 2020

Management and treatment of pheochromocytomas and paragangliomas.

1 reference

12 December 2020

Malignant pheochromocytoma: state of the field with future projections

1 reference

12 December 2020

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

1 reference

12 December 2020

Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.

1 reference

12 December 2020

Diagnostic management of benign and malignant pheochromocytoma

1 reference

12 December 2020

Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.

1 reference

12 December 2020

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

1 reference

12 December 2020

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.

1 reference

12 December 2020

Chromogranin A Expression in Phaeochromocytomas Associated with von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2

1 reference

12 December 2020

131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma

1 reference

12 December 2020

Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas

1 reference

12 December 2020

Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells

1 reference

12 December 2020

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

1 reference

12 December 2020

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy

1 reference

12 December 2020

111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.

1 reference

12 December 2020

Pheochromocytoma and extra-adrenal paraganglioma: updates

1 reference

12 December 2020

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

12 December 2020

Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma

1 reference

12 December 2020

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients

1 reference

12 December 2020

Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma

1 reference

12 December 2020

Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.

1 reference

12 December 2020

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma

1 reference

12 December 2020

[Somatostatin receptors expression (SSTR1-SSTR5) in pheochromocytomas]

1 reference

12 December 2020

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

1 reference

12 December 2020

Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score

1 reference

12 December 2020

Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO).

1 reference

12 December 2020

Somatostatin analogs for diagnosis and treatment of cancer

1 reference

12 December 2020

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

12 December 2020

Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases

1 reference

12 December 2020

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

1 reference

12 December 2020

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

12 December 2020

Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors

1 reference

12 December 2020

Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma

1 reference

12 December 2020

A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine

1 reference

12 December 2020

The management of benign and malignant pheochromocytoma and abdominal paraganglioma

1 reference

12 December 2020

VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome

1 reference

12 December 2020

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma

1 reference

12 December 2020

Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin

1 reference

12 December 2020

Somatostatin Receptor Subtypes in Human Pheochromocytoma: Subcellular Expression Pattern and Functional Relevance for Octreotide Scintigraphy

1 reference

12 December 2020

Laparoscopic adrenalectomy for pheochromocytoma

1 reference

12 December 2020

Preoperative and surgical therapy in sporadic and familial pheochromocytoma

1 reference

12 December 2020

Malignant pheochromocytoma

1 reference

12 December 2020

Malignant pheochromocytoma: current status and initiatives for future progress

1 reference

12 December 2020

Malignant phaeochromocytoma of the organ of Zuckerkandl with functioning metastases

1 reference

12 December 2020

Orbital Metastases from Extra-Adrenal Pheochromocytoma

1 reference

12 December 2020

Malignant pheochromocytoma in childhood

1 reference

12 December 2020

Attempted Treatment of Inoperable Pheochromocytoma With Streptozocin

1 reference

12 December 2020

Malignant pheochromocytoma (paraganglioma) of the organ of Zuckerkandl: a study of two cases

1 reference

12 December 2020

Treatment of Metastatic Pheochromocytoma With Streptozocin

1 reference

12 December 2020

Radiopharmaceutical treatment of malignant pheochromocytoma

1 reference

12 December 2020

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

12 December 2020

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

1 reference

12 December 2020

Targeted therapy for metastatic renal cell carcinoma

1 reference

12 December 2020

The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

1 reference

12 December 2020

The role of chromogranin A in the management of patients with phaeochromocytoma

1 reference

12 December 2020

An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges

1 reference

12 December 2020

Current trends in functional imaging of pheochromocytomas and paragangliomas.

1 reference

12 December 2020

Chemotherapy trials in malignant pheochromocytoma: Report of two patients and review of the literature

1 reference

12 December 2020

Treatment of malignant pheochromocytoma with combination chemotherapy

1 reference

12 December 2020

Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas

1 reference

12 December 2020

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

12 December 2020

Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment

1 reference

12 December 2020

Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil

1 reference

12 December 2020

Extra-adrenal pheochromocytoma

1 reference

12 December 2020

The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls

1 reference

12 December 2020

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience

1 reference

12 December 2020

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

1 reference

12 December 2020

Comparison of adrenal and extraadrenal pheochromocytomas

1 reference

12 December 2020

Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors

1 reference

12 December 2020

Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

12 December 2020

Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion

1 reference

12 December 2020

Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial

1 reference

12 December 2020

Plasma metanephrines in the diagnosis of pheochromocytoma

1 reference

12 December 2020

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

1 reference

12 December 2020

131I-MIBG therapy of neural crest tumours (review).

1 reference

12 December 2020

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

12 December 2020

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

12 December 2020

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

12 December 2020